SlideShare a Scribd company logo
www.eurordis.org




               EPIRARE:
Building Consensus and Synergies for the
EU Registration of Rare Disease Patients



                   Yann LE CAM
                Chief Executive Officer
                      EURORDIS
The EPIRARE project


    General Objectives:
    To build consensus and synergies to address the regulatory,
     ethical and technical issues associated with the registration of
     rare disease patients in Europe.
    To explore the feasibility of registration of minimum data set
     common to all rare disease
    To elaborate possible policy scenarios for EU policy on rare
     disease patients registries
    To prepare the feasibility of a future EU registry platform (legal
     basis, governance framework, option for sustainability, …).




2   The EPIRARE Project
The EPIRARE project

    A 30-month project

    Coordinated by the
    Istituto Superiore di Sanità (ISS) (Italian Ministry of Health)
                                        +
                                   2 private organisations
    10 Associated Partners:
                                   8 public institutions


     Total budget of 1.1M€
     (60% of which from the European Commission)



3    The EPIRARE Project
The EPIRARE project

    Organisation of the work:
           WP1- Coordination of the project
           WP2 - Dissemination of the project
           WP3 - Evaluation of the project
           WP4 - Legal basis
           WP5 - Policy Scenarios on the scope aims, governance and
            sustainability of registration of RD patients
           WP6 - Common data set and disease specific data collection
           WP7 - Data quality, validation and data sources integration
           WP8 – Current needs of EU registration on RD and platform
            facilities serving registration need


4    The EPIRARE Project
The EPIRARE project
                             WP1- Coordination of the
                                     project


                            WP8 – Current needs of EU
                            registration on RD and
                            platform facilities serving
                            registration need
    WP6 - Common
    data set and                                          WP4 - Legal basis
    disease specific        WP7 - Data quality,
    data collection         validation and data
                            sources integration


                          WP5 - Policy Scenarios on
                          the scope aims, governance
                          and sustainability of
          WP2 -           registration of RD patients          WP3 -
     Dissemination of                                       Evaluation of
        the project                                          the project

5   The EPIRARE Project
The EPIRARE project
WP8 – Current needs of EU registration on RD and platform
           facilities serving registration need
A survey to be conducted through existing registries, in order to collect
 information on existing registration initiatives within the interests not
 only of academicians and private companies, but also of the patients.
 Addressed aspects: scope and aims, legal base for collection of data,
 measures for data protection, organisational and financial support,
 number of patients registered, unmet needs, data collected, means of
 collection and quality of data and data sources.
A survey, conducted by EURORDIS, will also address experience and
 expectations of patients organizations regarding patient registries run
 by academic groups, industry or public administrations.
The information collected will be used to identify the services necessary
 to improve the quality, promote and facilitate the use of the registry
 platform and to report appropriately to the public and other
 stakeholders.

 6   The EPIRARE Project
The EPIRARE project
                           WP4 - Legal basis

       • This WP will assess the current transposition of the Data
          Protection Directive and in particular the transposition of
          Art. 8 of the Directive,
       • will consult EUCERD Member and other national policy
          makers and
       • will set out the elements (e.g.: scope of data collection, the
          nature of data to be collected, the data sources to be used)
          to generate a policy option (best practice model) which can
          be assured and implemented by national policy makers /
          institutions.




7   The EPIRARE Project
The EPIRARE project
WP6 - Common data set and disease specific data collection


        • This WP defines a common data set with correlated
          Standard Operating Procedures, which is independent
          of the registered rare disease, and of other disease-
          specific modules, in order to provide information
          consistent with the agreed scope of the registers which
          is useful for public health actions and for other aims.




8   The EPIRARE Project
The EPIRARE project
WP7 - Data quality, validation and data sources integration

This WP assesses:
a) the internal and external validity of existing data as well as the use of
  primary or secondary data sources and completeness of follow-up.
b) the need for performing an external quality control scheme to
  monitor compliance of platform registration activities to inclusion
  criteria
c) the need for the transnational pooling of collections on RD patients,
  in order to attain sufficient statistical power for clinical and public
  health investigations
c) the necessary data source integration and completeness of reporting
  to get reliable results with respect to different aims and data analysis
  and ways to assess it.
d) the opportunities offered by the collaboration of patients and POs in
  increasing the completeness of case registration.

9   The EPIRARE Project
The EPIRARE project
WP5 - Policy Scenarios on the scope aims, governance and
       sustainability of registration of RD patients

  • This WP addresses the scope, aims, governance and
    ownership of RD patient registration and develop possible
    policy scenarios.
  • Consensus will be build toward an agreed “common data set”
    for all RD registries and databases
  • Different options ensuring the long-term sustainability of the
    RD registers without affecting the independence and scientific
    value of the registration activities and products will also be
    assessed.
  • This work will be conducted by EURORDIS – ISS and all
    project partners - in close relation with the EUCERD, and it will
    support a specific workshops on “registries and data bases”.



10 The EPIRARE Project

More Related Content

What's hot

Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
EURORDIS - Rare Diseases Europe
 
Workshop 4 - "EURORDIS Research Policy recommendation"
Workshop 4 - "EURORDIS Research Policy recommendation"Workshop 4 - "EURORDIS Research Policy recommendation"
Workshop 4 - "EURORDIS Research Policy recommendation"
EURORDIS - Rare Diseases Europe
 
Conference 4 - The patient experience in the development and implementation ...
Conference 4 - The patient experience  in the development and implementation ...Conference 4 - The patient experience  in the development and implementation ...
Conference 4 - The patient experience in the development and implementation ...
EURORDIS - Rare Diseases Europe
 
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
EURORDIS - Rare Diseases Europe
 
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
EURORDIS - Rare Diseases Europe
 
Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...
Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...
Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...
EURORDIS - Rare Diseases Europe
 
Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"
EURORDIS - Rare Diseases Europe
 
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
EURORDIS - Rare Diseases Europe
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
EURORDIS - Rare Diseases Europe
 
Workshop 6 - "Case study: Italian Training for MDs,"
Workshop 6 - "Case study: Italian Training for MDs,"Workshop 6 - "Case study: Italian Training for MDs,"
Workshop 6 - "Case study: Italian Training for MDs,"
EURORDIS - Rare Diseases Europe
 
Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"
EURORDIS - Rare Diseases Europe
 
Rare Disease Day: Discussion of a good practice example: Mavris
Rare Disease Day: Discussion of a good practice example: MavrisRare Disease Day: Discussion of a good practice example: Mavris
Rare Disease Day: Discussion of a good practice example: Mavris
Nowgen
 
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
EURORDIS - Rare Diseases Europe
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI
 
Workshop 7 - "Folic acid prevents neural tubes defect"
Workshop 7 - "Folic acid prevents neural tubes defect"Workshop 7 - "Folic acid prevents neural tubes defect"
Workshop 7 - "Folic acid prevents neural tubes defect"
EURORDIS - Rare Diseases Europe
 
What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...
Nowgen
 
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI
 
Session 25 andrzej_rys
Session 25 andrzej_rysSession 25 andrzej_rys
Session 25 andrzej_rys
EURORDIS - Rare Diseases Europe
 
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Canadian Organization for Rare Disorders
 
Jornadas #PatientInHTA · Paloma Casado
Jornadas #PatientInHTA · Paloma CasadoJornadas #PatientInHTA · Paloma Casado
Jornadas #PatientInHTA · Paloma Casado
Instituto Aragonés de Ciencias de la Salud - IACS
 

What's hot (20)

Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
 
Workshop 4 - "EURORDIS Research Policy recommendation"
Workshop 4 - "EURORDIS Research Policy recommendation"Workshop 4 - "EURORDIS Research Policy recommendation"
Workshop 4 - "EURORDIS Research Policy recommendation"
 
Conference 4 - The patient experience in the development and implementation ...
Conference 4 - The patient experience  in the development and implementation ...Conference 4 - The patient experience  in the development and implementation ...
Conference 4 - The patient experience in the development and implementation ...
 
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
 
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
 
Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...
Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...
Workshop 5 - "Presentation of Social Challenges of RD patients in the Joint A...
 
Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"
 
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
 
Workshop 6 - "Case study: Italian Training for MDs,"
Workshop 6 - "Case study: Italian Training for MDs,"Workshop 6 - "Case study: Italian Training for MDs,"
Workshop 6 - "Case study: Italian Training for MDs,"
 
Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"
 
Rare Disease Day: Discussion of a good practice example: Mavris
Rare Disease Day: Discussion of a good practice example: MavrisRare Disease Day: Discussion of a good practice example: Mavris
Rare Disease Day: Discussion of a good practice example: Mavris
 
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
 
Workshop 7 - "Folic acid prevents neural tubes defect"
Workshop 7 - "Folic acid prevents neural tubes defect"Workshop 7 - "Folic acid prevents neural tubes defect"
Workshop 7 - "Folic acid prevents neural tubes defect"
 
What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...
 
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
 
Session 25 andrzej_rys
Session 25 andrzej_rysSession 25 andrzej_rys
Session 25 andrzej_rys
 
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
 
Jornadas #PatientInHTA · Paloma Casado
Jornadas #PatientInHTA · Paloma CasadoJornadas #PatientInHTA · Paloma Casado
Jornadas #PatientInHTA · Paloma Casado
 

Similar to Workshop 3 - "Presentation of the Epi-Rare project"

PanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo Haupt
PanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo HauptPanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo Haupt
PanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo Haupt
KylieOBrien10
 
2013-11 HIMSS "the French PHR/EHR"
2013-11 HIMSS "the French PHR/EHR"2013-11 HIMSS "the French PHR/EHR"
2013-11 HIMSS "the French PHR/EHR"
ASIP Santé
 
European Clinical Research Infrastructure Network
European Clinical Research Infrastructure NetworkEuropean Clinical Research Infrastructure Network
European Clinical Research Infrastructure Network
EURORDIS Rare Diseases Europe
 
La eHealth en général et quelques projets de la HES-SO Valais
La eHealth en général et quelques projets de la HES-SO ValaisLa eHealth en général et quelques projets de la HES-SO Valais
La eHealth en général et quelques projets de la HES-SO Valais
Institute of Information Systems (HES-SO)
 
Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...
Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...
Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...
Department of Health
 
Update regulatory standards landscape
Update   regulatory standards landscapeUpdate   regulatory standards landscape
Update regulatory standards landscape
Fred Miller
 
Legal and Ethical Issues of International Clinical Trials
Legal and Ethical Issues of International Clinical TrialsLegal and Ethical Issues of International Clinical Trials
Legal and Ethical Issues of International Clinical Trials
Wolfgang Kuchinke
 
DEC 3 2015 Mats Sundgren
DEC 3 2015 Mats SundgrenDEC 3 2015 Mats Sundgren
DEC 3 2015 Mats Sundgren
GBX Events
 
Dr Luthra: Retinal Diseases Registry
Dr Luthra: Retinal Diseases RegistryDr Luthra: Retinal Diseases Registry
Dr Luthra: Retinal Diseases Registry
retinaindia
 
DEMETER - Development of Methodologies and Systems for the Identification of ...
DEMETER - Development of Methodologies and Systems for the Identification of ...DEMETER - Development of Methodologies and Systems for the Identification of ...
DEMETER - Development of Methodologies and Systems for the Identification of ...
AGINFRA
 
ECDC projects and collaborations on digital surveillance
ECDC projects and collaborations on digital surveillanceECDC projects and collaborations on digital surveillance
ECDC projects and collaborations on digital surveillance
European Center for Disease Prevention and Control (ECDC)
 
CORBEL BBMRI-ERIC QM webinar slides
CORBEL BBMRI-ERIC QM webinar slidesCORBEL BBMRI-ERIC QM webinar slides
CORBEL BBMRI-ERIC QM webinar slides
CORBEL
 
Taruscio Domenica Torino 13° Convegno Patologia Immune E Malattie Orfane 21 2...
Taruscio Domenica Torino 13° Convegno Patologia Immune E Malattie Orfane 21 2...Taruscio Domenica Torino 13° Convegno Patologia Immune E Malattie Orfane 21 2...
Taruscio Domenica Torino 13° Convegno Patologia Immune E Malattie Orfane 21 2...
cmid
 
2014 11-19 rb progressive fieldevaluationmerck
2014 11-19 rb progressive fieldevaluationmerck2014 11-19 rb progressive fieldevaluationmerck
2014 11-19 rb progressive fieldevaluationmerck
Reiner Banken
 
Connected health data meets the people: Diversity, Standards, and Trust
Connected health data meets the people: Diversity, Standards, and TrustConnected health data meets the people: Diversity, Standards, and Trust
Connected health data meets the people: Diversity, Standards, and Trust
chronaki
 
International regulatory cooperation: more important than ever
International regulatory cooperation: more important than everInternational regulatory cooperation: more important than ever
International regulatory cooperation: more important than ever
TGA Australia
 
PharmaLedger Press Release #2 June 2020
PharmaLedger Press Release #2 June 2020 PharmaLedger Press Release #2 June 2020
PharmaLedger Press Release #2 June 2020
PharmaLedger
 
PharmaLedger Official Presentation Overview
PharmaLedger Official Presentation OverviewPharmaLedger Official Presentation Overview
PharmaLedger Official Presentation Overview
PharmaLedger
 
Joint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceJoint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task Force
Dutch Orphan Drug Network
 
CINECA webinar slides: Status Update Code of Conduct: Teaming up & Talking ab...
CINECA webinar slides: Status Update Code of Conduct: Teaming up & Talking ab...CINECA webinar slides: Status Update Code of Conduct: Teaming up & Talking ab...
CINECA webinar slides: Status Update Code of Conduct: Teaming up & Talking ab...
CINECAProject
 

Similar to Workshop 3 - "Presentation of the Epi-Rare project" (20)

PanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo Haupt
PanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo HauptPanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo Haupt
PanCareSurPass @SIOP Europe/CCI Europe Meeting 2021, Riccardo Haupt
 
2013-11 HIMSS "the French PHR/EHR"
2013-11 HIMSS "the French PHR/EHR"2013-11 HIMSS "the French PHR/EHR"
2013-11 HIMSS "the French PHR/EHR"
 
European Clinical Research Infrastructure Network
European Clinical Research Infrastructure NetworkEuropean Clinical Research Infrastructure Network
European Clinical Research Infrastructure Network
 
La eHealth en général et quelques projets de la HES-SO Valais
La eHealth en général et quelques projets de la HES-SO ValaisLa eHealth en général et quelques projets de la HES-SO Valais
La eHealth en général et quelques projets de la HES-SO Valais
 
Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...
Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...
Global Dementia Legacy Event: Canada & France: Dr Etienne Hirsch & Dr Yves Jo...
 
Update regulatory standards landscape
Update   regulatory standards landscapeUpdate   regulatory standards landscape
Update regulatory standards landscape
 
Legal and Ethical Issues of International Clinical Trials
Legal and Ethical Issues of International Clinical TrialsLegal and Ethical Issues of International Clinical Trials
Legal and Ethical Issues of International Clinical Trials
 
DEC 3 2015 Mats Sundgren
DEC 3 2015 Mats SundgrenDEC 3 2015 Mats Sundgren
DEC 3 2015 Mats Sundgren
 
Dr Luthra: Retinal Diseases Registry
Dr Luthra: Retinal Diseases RegistryDr Luthra: Retinal Diseases Registry
Dr Luthra: Retinal Diseases Registry
 
DEMETER - Development of Methodologies and Systems for the Identification of ...
DEMETER - Development of Methodologies and Systems for the Identification of ...DEMETER - Development of Methodologies and Systems for the Identification of ...
DEMETER - Development of Methodologies and Systems for the Identification of ...
 
ECDC projects and collaborations on digital surveillance
ECDC projects and collaborations on digital surveillanceECDC projects and collaborations on digital surveillance
ECDC projects and collaborations on digital surveillance
 
CORBEL BBMRI-ERIC QM webinar slides
CORBEL BBMRI-ERIC QM webinar slidesCORBEL BBMRI-ERIC QM webinar slides
CORBEL BBMRI-ERIC QM webinar slides
 
Taruscio Domenica Torino 13° Convegno Patologia Immune E Malattie Orfane 21 2...
Taruscio Domenica Torino 13° Convegno Patologia Immune E Malattie Orfane 21 2...Taruscio Domenica Torino 13° Convegno Patologia Immune E Malattie Orfane 21 2...
Taruscio Domenica Torino 13° Convegno Patologia Immune E Malattie Orfane 21 2...
 
2014 11-19 rb progressive fieldevaluationmerck
2014 11-19 rb progressive fieldevaluationmerck2014 11-19 rb progressive fieldevaluationmerck
2014 11-19 rb progressive fieldevaluationmerck
 
Connected health data meets the people: Diversity, Standards, and Trust
Connected health data meets the people: Diversity, Standards, and TrustConnected health data meets the people: Diversity, Standards, and Trust
Connected health data meets the people: Diversity, Standards, and Trust
 
International regulatory cooperation: more important than ever
International regulatory cooperation: more important than everInternational regulatory cooperation: more important than ever
International regulatory cooperation: more important than ever
 
PharmaLedger Press Release #2 June 2020
PharmaLedger Press Release #2 June 2020 PharmaLedger Press Release #2 June 2020
PharmaLedger Press Release #2 June 2020
 
PharmaLedger Official Presentation Overview
PharmaLedger Official Presentation OverviewPharmaLedger Official Presentation Overview
PharmaLedger Official Presentation Overview
 
Joint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceJoint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task Force
 
CINECA webinar slides: Status Update Code of Conduct: Teaming up & Talking ab...
CINECA webinar slides: Status Update Code of Conduct: Teaming up & Talking ab...CINECA webinar slides: Status Update Code of Conduct: Teaming up & Talking ab...
CINECA webinar slides: Status Update Code of Conduct: Teaming up & Talking ab...
 

More from EURORDIS - Rare Diseases Europe

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...
EURORDIS - Rare Diseases Europe
 
RareConnect.org Update 2016
RareConnect.org Update 2016RareConnect.org Update 2016
RareConnect.org Update 2016
EURORDIS - Rare Diseases Europe
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare disease
EURORDIS - Rare Diseases Europe
 
Living with TRAPS poll results
Living with TRAPS poll resultsLiving with TRAPS poll results
Living with TRAPS poll results
EURORDIS - Rare Diseases Europe
 
Pitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.orgPitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.org
EURORDIS - Rare Diseases Europe
 
The Value of Online Communities
The Value of Online CommunitiesThe Value of Online Communities
The Value of Online Communities
EURORDIS - Rare Diseases Europe
 
Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014
EURORDIS - Rare Diseases Europe
 
Update on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgUpdate on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.org
EURORDIS - Rare Diseases Europe
 
Surveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org ExperienceSurveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org Experience
EURORDIS - Rare Diseases Europe
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients Globally
EURORDIS - Rare Diseases Europe
 
Rare disease day 2011 highlights
Rare disease day 2011 highlightsRare disease day 2011 highlights
Rare disease day 2011 highlights
EURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
EURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
EURORDIS - Rare Diseases Europe
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...
EURORDIS - Rare Diseases Europe
 
Conference 3 "Outcomes of 15 National Conferences, "
Conference 3   "Outcomes of 15 National Conferences, "Conference 3   "Outcomes of 15 National Conferences, "
Conference 3 "Outcomes of 15 National Conferences, "
EURORDIS - Rare Diseases Europe
 
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe" Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
EURORDIS - Rare Diseases Europe
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...
EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
EURORDIS - Rare Diseases Europe
 

More from EURORDIS - Rare Diseases Europe (18)

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...
 
RareConnect.org Update 2016
RareConnect.org Update 2016RareConnect.org Update 2016
RareConnect.org Update 2016
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare disease
 
Living with TRAPS poll results
Living with TRAPS poll resultsLiving with TRAPS poll results
Living with TRAPS poll results
 
Pitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.orgPitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.org
 
The Value of Online Communities
The Value of Online CommunitiesThe Value of Online Communities
The Value of Online Communities
 
Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014
 
Update on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgUpdate on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.org
 
Surveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org ExperienceSurveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org Experience
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients Globally
 
Rare disease day 2011 highlights
Rare disease day 2011 highlightsRare disease day 2011 highlights
Rare disease day 2011 highlights
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...
 
Conference 3 "Outcomes of 15 National Conferences, "
Conference 3   "Outcomes of 15 National Conferences, "Conference 3   "Outcomes of 15 National Conferences, "
Conference 3 "Outcomes of 15 National Conferences, "
 
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe" Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
 

Recently uploaded

Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 

Recently uploaded (20)

Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 

Workshop 3 - "Presentation of the Epi-Rare project"

  • 1. www.eurordis.org EPIRARE: Building Consensus and Synergies for the EU Registration of Rare Disease Patients Yann LE CAM Chief Executive Officer EURORDIS
  • 2. The EPIRARE project General Objectives: To build consensus and synergies to address the regulatory, ethical and technical issues associated with the registration of rare disease patients in Europe. To explore the feasibility of registration of minimum data set common to all rare disease To elaborate possible policy scenarios for EU policy on rare disease patients registries To prepare the feasibility of a future EU registry platform (legal basis, governance framework, option for sustainability, …). 2 The EPIRARE Project
  • 3. The EPIRARE project A 30-month project Coordinated by the Istituto Superiore di Sanità (ISS) (Italian Ministry of Health) + 2 private organisations 10 Associated Partners: 8 public institutions Total budget of 1.1M€ (60% of which from the European Commission) 3 The EPIRARE Project
  • 4. The EPIRARE project Organisation of the work: WP1- Coordination of the project WP2 - Dissemination of the project WP3 - Evaluation of the project WP4 - Legal basis WP5 - Policy Scenarios on the scope aims, governance and sustainability of registration of RD patients WP6 - Common data set and disease specific data collection WP7 - Data quality, validation and data sources integration WP8 – Current needs of EU registration on RD and platform facilities serving registration need 4 The EPIRARE Project
  • 5. The EPIRARE project WP1- Coordination of the project WP8 – Current needs of EU registration on RD and platform facilities serving registration need WP6 - Common data set and WP4 - Legal basis disease specific WP7 - Data quality, data collection validation and data sources integration WP5 - Policy Scenarios on the scope aims, governance and sustainability of WP2 - registration of RD patients WP3 - Dissemination of Evaluation of the project the project 5 The EPIRARE Project
  • 6. The EPIRARE project WP8 – Current needs of EU registration on RD and platform facilities serving registration need A survey to be conducted through existing registries, in order to collect information on existing registration initiatives within the interests not only of academicians and private companies, but also of the patients. Addressed aspects: scope and aims, legal base for collection of data, measures for data protection, organisational and financial support, number of patients registered, unmet needs, data collected, means of collection and quality of data and data sources. A survey, conducted by EURORDIS, will also address experience and expectations of patients organizations regarding patient registries run by academic groups, industry or public administrations. The information collected will be used to identify the services necessary to improve the quality, promote and facilitate the use of the registry platform and to report appropriately to the public and other stakeholders. 6 The EPIRARE Project
  • 7. The EPIRARE project WP4 - Legal basis • This WP will assess the current transposition of the Data Protection Directive and in particular the transposition of Art. 8 of the Directive, • will consult EUCERD Member and other national policy makers and • will set out the elements (e.g.: scope of data collection, the nature of data to be collected, the data sources to be used) to generate a policy option (best practice model) which can be assured and implemented by national policy makers / institutions. 7 The EPIRARE Project
  • 8. The EPIRARE project WP6 - Common data set and disease specific data collection • This WP defines a common data set with correlated Standard Operating Procedures, which is independent of the registered rare disease, and of other disease- specific modules, in order to provide information consistent with the agreed scope of the registers which is useful for public health actions and for other aims. 8 The EPIRARE Project
  • 9. The EPIRARE project WP7 - Data quality, validation and data sources integration This WP assesses: a) the internal and external validity of existing data as well as the use of primary or secondary data sources and completeness of follow-up. b) the need for performing an external quality control scheme to monitor compliance of platform registration activities to inclusion criteria c) the need for the transnational pooling of collections on RD patients, in order to attain sufficient statistical power for clinical and public health investigations c) the necessary data source integration and completeness of reporting to get reliable results with respect to different aims and data analysis and ways to assess it. d) the opportunities offered by the collaboration of patients and POs in increasing the completeness of case registration. 9 The EPIRARE Project
  • 10. The EPIRARE project WP5 - Policy Scenarios on the scope aims, governance and sustainability of registration of RD patients • This WP addresses the scope, aims, governance and ownership of RD patient registration and develop possible policy scenarios. • Consensus will be build toward an agreed “common data set” for all RD registries and databases • Different options ensuring the long-term sustainability of the RD registers without affecting the independence and scientific value of the registration activities and products will also be assessed. • This work will be conducted by EURORDIS – ISS and all project partners - in close relation with the EUCERD, and it will support a specific workshops on “registries and data bases”. 10 The EPIRARE Project